Baseline Brain Metabolism in Resistant Depression and Response to Transcranial Magnetic Stimulation
Open accessAbstract
Neuroimaging studies of patients with treatment-resistant depression (TRD) have reported abnormalities in the frontal and temporal regions. We sought to determine whether metabolism in these regions might be related to response to repetitive transcranial magnetic stimulation (TMS) in patients with TRD. Magnetic resonance images and baseline resting-state cerebral glucose uptake index (gluMI) obtained using (18)F-fluorodeoxyglucose positron emission tomography were analyzed in TRD patients who had participated in a double-blind, randomized, sham-controlled trial of prefrontal 10 Hz TMS. Among the patients randomized to active TMS, 17 responders, defined as having 50% depression score decrease, and 14 nonresponders were investigated for prestimulation glucose metabolism and compared with 39 healthy subjects using a voxel-based analysis. In nonresponders relative to responders, gluMI was lower in left lateral orbitofrontal cortex (OFC), and higher in left amygdala and uncinate fasciculus. OFC and amygdala gluMI negatively correlated in nonresponders, positively correlated in responders, and did not correlate in healthy subjects. Relative to healthy subjects, both responders and nonresponders displayed lower gluMI in right dorsolateral prefrontal (DLPFC), right anterior cingulate (ACC), and left ventrolateral prefrontal cortices. Additionally, nonresponders had lower gluMI in left DLPFC, ACC, left and right insula, and higher gluMI in left amygdala and uncus. Hypometabolisms were partly explained by gray matter reductions, whereas hypermetabolisms were unrelated to structural changes. The findings suggest that different patterns of frontal-temporal-limbic abnormalities may distinguish responders and nonresponders to prefrontal magnetic stimulation. Both preserved OFC volume and amygdala metabolism might precondition response to TMS.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Antidepressant effects of low-dose ketamine and transcranial magnetic stimulation can improve cerebral glucose metabolism in these regions.
“Antidepressant effects of low-dose ketamine [56] and transcranial magnetic stimulation can improve the cerebral glucose metabolism in these regions [57–60].”
From APOE4 genotype exacerbates the depression-like behavior of mice during aging through ATP decline (2021) · cites this paper as [59]
The Introduction says high-frequency TMS aims to increase metabolism in prefrontal areas and notes its clinical effectiveness in treatment-resistant depression. But the study measured glucose metabolism before stimulation, not whether TMS improved it afterward; it therefore does not establish the claimed metabolic improvement. The ketamine claim is attached to a different citation and is not assessed here. (LLM, conf=0.84)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Drevets, W. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00102-5 · Cited by 581 · see citing works
Bipolar and major depressive disorder: Neuroimaging the developmental-degenerative divide
Savitz, J., & Drevets, W. C. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.01.004 · Cited by 494 · see citing works
Flagged first, then by citations
Research works printed but not linked: 7
- Herrmann LL, Ebmeier KP (2006). Factors modifying the efficacy of transcranial magnetic stimulation in the treatment of depression: a review. J Clin Psychiatry 67: 1870-1876.
- Hooker CI, Knight RT (2006). The role of the lateral orbitofrontal cortex in the inhibitory control of emotion. In: Zald DH, Rauch SL (eds). The Orbitofrontal Cortex. Oxford University Press: Oxford, 307-324.
- Lam RW, Chan P, Wilkins-Ho M, Yatham LN (2008). Repetitive transcranial magnetic stimulation for treatment-resistant de- pression: a systematic review and metaanalysis. Can J Psychiatry 53: 621-631.
- Loo CK, Mitchell PB (2005). A review of the efficacy of transcranial magnetic stimulation (TMS) treatment for depression, and current and future strategies to optimize efficacy. J Affect Disord 88: 255-267.
- Schmahmann JD, Pandya DN (2006). Uncinate fasciculus. In: Schmahmann JD, Pandya DN (eds). Fiber Pathways of the Brain. Oxford University Press: New York, 419-425.
- Talairach J, Tournoux P (1988). Co-Planar Stereotaxic Atlas of the Human Brain: An Approach to Medical Cerebral Imaging. Thieme Medical Publishers: New York.
- Videbech P (2000). PET measurements of brain glucose metabo- lism and blood flow in major depressive disorder: a critical review. Acta Psychiatr Scand 101: 11-20.
Cited by
Sorted by citations
Lefaucheur, J.-P., André-Obadia, N., Antal, A., Ayache, S. S., Baeken, C., Benninger, D. H., Cantello, R. M., Cincotta, M., de Carvalho, M., De Ridder, D., et al. (2014) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.05.021 · Cited by 2,119 · see citing works
Self-citationNew targets for rTMS in depression: A review of convergent evidence
Downar, J., & Daskalakis, Z. J. (2013) · Brain Stimulation · doi:10.1016/j.brs.2012.08.006 · Cited by 257 · see citing works
Neuroimaging-based biomarkers for treatment selection in major depressive disorder
Dunlop, B. W., & Mayberg, H. S. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.4/bdunlop · Cited by 127 · see citing works
Neural correlates during working memory processing in major depressive disorder
Wang, X.-L., Du, M.-Y., Chen, T.-L., Chen, Z.-Q., Huang, X.-Q., Luo, Y., Zhao, Y.-J., Kumar, P., & Gong, Q.-Y. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.08.011 · Cited by 89 · see citing works
Role of glutamate receptors and glial cells in the pathophysiology of treatment-resistant depression
Kim, Y.-K., & Na, K.-S. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.03.009 · Cited by 84 · see citing works
APOE4 genotype exacerbates the depression-like behavior of mice during aging through ATP decline
Fang, W., Xiao, N., Zeng, G., Bi, D., Dai, X., Mi, X., Ye, Q., Chen, X., & Zhang, J. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01631-0 · Cited by 42 · see citing works
- Authors
- Martinot, M.-L. P., Martinot, J.-L., Ringuenet, D., Galinowski, A., Gallarda, T., Bellivier, F., Lefaucheur, J.-P., Lemaitre, H., & Artiges, E.
- Affiliations
- Sorbonne Paris Cité (FR)
- Université Paris-Sud (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Inserm (FR)
- Corresponding author
- Martinot, Marie-Laure Paillère
- ORCID
- Venue
- Neuropsychopharmacology
- Published
- 2011-08-17
- Volume
- 36
- Issue
- 13
- Pages
- 2710-2719
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- PMC
- PMC3230494
- OpenAlex
- W2025577790
- Cited by
- 55
- References
- 2
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 1 · 2023: 2 · 2022: 8 · 2021: 6 · 2019: 2 · 2018: 2 · 2017: 5 · 2016: 4 · 2015: 4 · 2014: 7 · 2013: 2 · 2012: 4
- FWCI
- 2.53
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
- Funders
- Institut National de la Santé et de la Recherche Médicale
- Topics
- Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- treatment-resistant depression, repetitive transcranial magnetic stimulation, brain glucose metabolism, orbitofrontal cortex, amygdala, uncinate fasciculus, dorsolateral prefrontal cortex, anterior cingulate cortex, insula, treatment response prediction, gray matter reduction
- MeSH terms
- Adult, Aged, Brain, Brain Diseases, Metabolic, Double-Blind Method, Female, Humans, Male, Middle Aged, Radionuclide Imaging, Transcranial Magnetic Stimulation, Depressive Disorder, Treatment-Resistant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review